These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25944686)

  • 21. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts.
    Borrow J; Goddard AD; Gibbons B; Katz F; Swirsky D; Fioretos T; Dube I; Winfield DA; Kingston J; Hagemeijer A
    Br J Haematol; 1992 Nov; 82(3):529-40. PubMed ID: 1486033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.
    Tang FF; Lu SY; Zhao XS; Qin YZ; Liu XH; Jia JS; Wang J; Gong LZ; Jiang Q; Zhao T; Shi HX; Chang YJ; Huang XJ; Jiang H
    Br J Haematol; 2021 Dec; 195(5):722-730. PubMed ID: 34405393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia.
    Santamaría C; Chillón MC; Fernández C; Martín-Jiménez P; Balanzategui A; García Sanz R; San Miguel JF; González MG
    Haematologica; 2007 Mar; 92(3):315-22. PubMed ID: 17339180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report.
    Lauricella C; Greco R; Mancini V; Motta V; Ciraolo A; De Canal G; De Paoli E; Paglino G; Guido V; Bonoldi E; Veronese S; Soriani S
    Acta Haematol; 2023; 146(1):58-64. PubMed ID: 36198282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].
    Lin J; Han LX; Qian J; Wang YL; Qian Z; Yang XF; Sheng XJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of PML/RARa transcript after induction predicts outcome in children with acute promyelocytic leukemia.
    Zhang L; Cao Z; Zou Y; Ruan M; Li Q; Wang J; Zhu X
    Int J Hematol; 2012 May; 95(5):500-8. PubMed ID: 22407853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary near-tetraploidy with double der(15)t(15;17) in acute promyelocytic leukemia in relapse.
    Morita Y; Takahashi A; Yamamoto K; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2004 Mar; 149(2):131-6. PubMed ID: 15036889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR.
    Rossi V; Levati L; Biondi A
    Methods Mol Med; 2006; 125():115-26. PubMed ID: 16502581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of Exosomal PML-RARA Fusion Gene Expression Level by Droplet Digital PCR].
    Zhu H; Wang ZY; Ding XQ; Wang RX; Pan XR; Tong JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):747-752. PubMed ID: 31204926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic PML/RARA on chromosome 15 by metaphase FISH].
    Kashima E; Sugimoto Y; Nato Y; Ino K; Tawara I; Masuya M; Katayama N
    Rinsho Ketsueki; 2020; 61(11):1577-1583. PubMed ID: 33298649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia.
    Jiang XW; Chen SZ; Zhu XY; Xu XX; Liu Y
    Mol Cell Probes; 2020 Oct; 53():101617. PubMed ID: 32585184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.
    Grimwade D; Jovanovic JV; Hills RK; Nugent EA; Patel Y; Flora R; Diverio D; Jones K; Aslett H; Batson E; Rennie K; Angell R; Clark RE; Solomon E; Lo-Coco F; Wheatley K; Burnett AK
    J Clin Oncol; 2009 Aug; 27(22):3650-8. PubMed ID: 19506161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.
    Dekking EH; van der Velden VH; Varro R; Wai H; Böttcher S; Kneba M; Sonneveld E; Koning A; Boeckx N; Van Poecke N; Lucio P; Mendonça A; Sedek L; Szczepański T; Kalina T; Kanderová V; Hoogeveen P; Flores-Montero J; Chillón MC; Orfao A; Almeida J; Evans P; Cullen M; Noordijk AL; Vermeulen PM; de Man MT; Dixon EP; Comans-Bitter WM; van Dongen JJ;
    Leukemia; 2012 Sep; 26(9):1976-85. PubMed ID: 22948489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of increased PML-RARa transcripts after induction therapy for acute promyelocytic leukaemia.
    Liang M; Wang L; Xiao M; Xiong J; Wang J; Wang Z; Huang W; Zhou J
    Ann Med; 2020 Aug; 52(5):233-238. PubMed ID: 32323584
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia.
    Ismail S; Ababneh N; Awidi A
    Acta Haematol; 2007; 118(3):183-7. PubMed ID: 17934255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.
    Lou Y; Ma Y; Suo S; Ni W; Wang Y; Pan H; Tong H; Qian W; Meng H; Mai W; Huang J; Yu W; Wei J; Mao L; Jin J
    Leuk Res; 2015 Sep; 39(9):938-44. PubMed ID: 26183877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.